Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
life sciences
national blog main
ucb
2
×
abaloparatide
alexion pharmaceuticals
amgen
amyotrophic lateral sclerosis (als)
autoimmune disorders
boston
boston blog main
boston top stories
complement system
deals
europe blog main
europe top stories
european commission
generalized myasthenia gravis
immune-mediated necrotizing myopathy
national
osteoporosis
ra pharmaceuticals
radius health
rare disease drugs
romosozumab
san francisco blog main
san francisco top stories
teriparatide
zilucoplan
What
drug
alternative
amgen
amgen’s
approval
autoimmune
candidate
carries
deal
developed
disease
europe
european
expensive
heart
lead
marketing
medicine
medicines
nod
osteoporosis
pharma
pharmaceuticals
potential
ra
raise
risk
stakes
territory
ucb
viewed
warning
wins
world
Language
unset
2
×
Current search:
ucb
×
unset
×
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
